| Literature DB >> 35884328 |
Alberto Pasquarelli1, Luiz Henrique Silva Andrilli2, Maytê Bolean2, Claudio Reis Ferreira2, Marcos Antônio Eufrásio Cruz2, Flavia Amadeu de Oliveira3, Ana Paula Ramos2, José Luis Millán3, Massimo Bottini4, Pietro Ciancaglini2.
Abstract
This report describes the innovative application of high sensitivity Boron-doped nanocrystalline diamond microelectrodes for tracking small changes in Ca2+ concentration due to binding to Annexin-A5 inserted into the lipid bilayer of liposomes (proteoliposomes), which could not be assessed using common Ca2+ selective electrodes. Dispensing proteoliposomes to an electrolyte containing 1 mM Ca2+ resulted in a potential jump that decreased with time, reaching the baseline level after ~300 s, suggesting that Ca2+ ions were incorporated into the vesicle compartment and were no longer detected by the microelectrode. This behavior was not observed when liposomes (vesicles without AnxA5) were dispensed in the presence of Ca2+. The ion transport appears Ca2+-selective, since dispensing proteoliposomes in the presence of Mg2+ did not result in potential drop. The experimental conditions were adjusted to ensure an excess of Ca2+, thus confirming that the potential reduction was not only due to the binding of Ca2+ to AnxA5 but to the transfer of ions to the lumen of the proteoliposomes. Ca2+ uptake stopped immediately after the addition of EDTA. Therefore, our data provide evidence of selective Ca2+ transport into the proteoliposomes and support the possible function of AnxA5 as a hydrophilic pore once incorporated into lipid membrane, mediating the mineralization initiation process occurring in matrix vesicles.Entities:
Keywords: Annexin A5; diamond microelectrode; potential transient; proteoliposome; selective calcium transport
Mesh:
Substances:
Year: 2022 PMID: 35884328 PMCID: PMC9313143 DOI: 10.3390/bios12070525
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1The microelectrodes chip. (a) Layout of the 10 × 10 mm device; (b,c) progressive magnifications of the core region with the microelectrodes; (d) scheme of device cross-section showing the various layers and features; (e) SEM-picture showing the cross-section of the material stack before the deposition of the passivation layer; (f) assembled chip with the 200 µL sensing chamber; (g) micrograph showing the same region depicted in (c) of the actual chip.
Figure 2AFM phase images of 9:1 DPPC:DPPS (molar ratio) vesicles (0.6 mg mL−1) of (A) liposomes (2.5 × 2.5 μm scales); (B) zoomed detail of only one vesicle; (C) proteoliposomes harboring AnxA5 (1:100 protein:lipid, molar ratio) (2.5 × 2.5 μm scales); (D) zoomed detail of only one vesicle.
Figure 3Potential (V) versus time (s) curves recorded using the BNCD microelectrode in the presence of deionized water. A volume of 10 µL of liposomes (0.6 mg/mL of total lipid) (dot line) or proteoliposomes (0.6 mg/mL of total lipid containing 14 µg/mL of AnxA5) (continuous line) were added to the microelectrode compartment after 300 s. After initial equilibration a nearly stable baseline was reached. Since this equilibration is not relevant for the signal analysis, the following figures focus on the time range from 200 to 600 s. The potential steps observed after dispensing the vesicles are due, in this case, to the Tris-HCl buffered vesicle solutions, since no other ions are present. Such steps drop down by a few tens of millivolts over the next 300 s, indicating a second equilibration transient. The inset shows the device inserted in the readout electronics inside the shield box and the dispensing of the vesicle sample by manual pipetting.
Figure 4Potential (V) versus time (s) curve recorded with the BNCD microelectrode in the presence of either Mg2+ or Ca2+ ions in deionized water. After the first equilibration, 10 µL of liposomes (0.6 mg/mL of total lipid) (dot lines) or proteoliposomes (0.6 mg/mL of total lipid containing 14 µg/mL of AnxA5) (continuous lines) were added at 300 s to the microelectrode compartment. Black lines correspond to the potential recordings in the presence of 1 mM Ca2+ ions and red lines to potential recordings in the presence of 1 mM Mg2+ ions. Inset: Absolute values of the potential changes observed from 300 to 600 s, i.e., over the long-term transient after the addition of vesicles.
Figure 5Potential (V) versus time (s) recorded with the BNCD microelectrode in media containing 1 mM Ca2+ ions in 16 mM Tris-buffer, pH 7.5. After equilibration, 4 µL of 2.5 mM EDTA were added at 240 s to the microelectrode followed by the addition of 10 µL of liposomes (0.6 mg/mL of total lipid) (dot line) or proteoliposomes (0.6 mg/mL of total lipid containing 14 µg/mL of AnxA5) (continuous line) at 300 s. The chelator prevents internalization of Ca2+ ions by the proteoliposomes and the potential fluctuates in a small range of just a few tens of mV. Due to the presence of the Tris-buffer from the beginning, the potential steps are much smaller than the ones shown in the previous figures. The signal fluctuations are artifacts due to vibrations and turbulences generated by the manual pipetting technique. Despite of such fluctuations, both recordings end at a level of ~30 mV above the baseline, which suggests the absence of ion transport due to the chelating action of EDTA.
Figure 6Potential (V) versus time (s) curve recorded using the BNCD microelectrode in media containing 1 mM of Ca2+ ions in Tris 16 mM, pH 7.5. After equilibration, at 300 s, 10 µL of liposomes (0.6 mg/mL of total lipid) (dotted line) and proteoliposomes (0.6 mg/mL of total lipid containing 14 µg/mL of AnxA5) (continuous line) were added, followed by the addition of 4 µL of 2.5 mM EDTA at 360 s. A potential drop of ~30 mV is clearly visible from 300 to 360 s in the recording with proteoliposomes.
Summary of all measurement variations and the respective results. Recordings 1 to 4 and 17 are negative controls, i.e., without liposomes/proteoliposomes. All measurements with Tris-buffer in the initial solution present smaller potential variations due to the buffering effect.
| #Recording | Aim | Initial | 1st | 2nd | Results |
|---|---|---|---|---|---|
| 1 | Test capacitive effects of volume changes | 1 mM Ca2+ in water | 1 mM Ca2+ in water | - | Stable potential |
| 2 | 1 mM Mg2+ in water | 1 mM Mg2+ in water | - | ||
| 3 | Test potential change by buffer dispensing | 1 mM Ca2+ in water | Tris (16 mM pH 7.5) | - | ~150 mV step with second equilibration |
| 4 | 1 mM Mg2+ in water | Tris(16 mM pH 7.5) | - | ||
| 5 | Test liposome | 1 mM Mg2+ in water | Tris + Lipo | - | ~150 mV step with |
| 6 | Test proteoliposome response to Mg2+ | 1 mM Mg2+ in water | Tris + Proteo | - | ~130 mV step with small drop vs. time |
| 7 | Test liposome | 1 mM Ca2+ in water | Tris + Lipo | - | ~140 mV step with |
| 8 | Test proteoliposome response to Ca2+ | 1 mM Ca2+ in water | Tris + Proteo | - | ~120 mV step, drops to baseline |
| 9 | Test liposome | 1 mM Mg2+ in Tris | Tris + Lipo | - | ~40 mV step with |
| 10 | Test proteoliposome response to Mg2+ in buffer | 1 mM Mg2+ in Tris | Tris + Proteo | - | ~30 mV step with second equilibration |
| 11 | Test liposome | 1 mM Ca2+ in Tris | Tris + Lipo | - | ~40 mV step with second equilibration |
| 12 | Test proteoliposome response to Ca2+ in buffer | 1 mM Ca2+ in Tris | Tris + Proteo | - | ~30 mV potential step, drops to baseline |
| 13 | Test liposome | 1 mM Na+ in water | Tris + Lipo | - | ~220 mV step with |
| 14 | Test proteoliposome response to Na+ | 1 mM Na+ in water | Tris + Proteo | - | ~200 mV step with |
| 15 | Test liposome | 1 mM Na+ in Tris | Tris + Lipo | - | ~20 mV potential step |
| 16 | Test proteoliposome response to Na+ in buffer | 1 mM Na+ in Tris | Tris + Proteo | - | ~10 mV potential step |
| 17 | Test potential change by chelator dispensing | 1 mM Ca2+ in Tris | EDTA | ~20 mV negative step | |
| 18 | Test chelator effect | 1 mM Ca2+ in Tris | Tris + Lipo | EDTA | (1) ~20 mV steady step |
| 19 | Test chelator effect | 1 mM Ca2+ in Tris | Tris + Proteo | EDTA | (1) ~30 mV dropping slope |
| 20 | Test chelator effect | 1 mM Ca2+ in Tris | EDTA | Tris + Lipo | (1) ~40 mV negative step |
| 21 | Test chelator effect | 1 mM Ca2+ in Tris | EDTA | Tris + Proteo | (1) ~40 mV negative step |
| 22 | Test chelator effect | 1 mM Ca2+ in Tris + EDTA | Tris + Proteo | ~30 mV steady step |